Multimodal single-cell analyses reveal distinct fusion-regulated transcriptional programs in Ewing sarcoma
eLife · 11.11.2026 · 14
DOI: 10.7554/elife.109124 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 11.11.2026. Verfasst von Olivia G Waltner und 13 weiteren Autor:innen. Beteiligte Einrichtung: Translational Science and Therapeutics Division, Fred Hutch Cancer Center, Seattle, United States. Hauptthemen laut MEDLINE: Sarcoma, Ewing, Oncogene Proteins, Fusion, Single-Cell Analysis, RNA-Binding Protein EWS. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, AACR-QuadW Foundation Sarcoma Research Fellowship.
Abstract (Originalsprache)
Ewing sarcoma (EwS) is a fusion-driven malignancy, peaking in adolescence. Although EwS tumors are driven uniquely by EWS::FLI1 and related fusions, patient outcomes vary greatly. If and how tumor plasticity of EWS::FLI1-regulated transcriptional signatures contributes to disease progression is not known. To address this, we utilized a single-cell co-assay of RNA and chromatin accessibility (ATAC) sequencing to identify gene regulatory networks in EwS. By comprehensively characterizing regulatory elements across cell lines, we identified multiple unique modules of gene regulation. Differential usage and prevalence of these modules was evident across cell lines, associated with distinct epigenetic and transcriptomic signatures, and in specific cases, modifiable by exogenous TGF-β. When we examined primary EwS patient tumors, we observed these same regulatory modules were variably enriched both across and within tumors, highlighting the existence of intratumoral heterogeneity in gene regulatory networks. Our findings demonstrate that multiple, co-existing transcriptional programs shape the phenotypic diversity of EwS and suggest that the balance between these networks may have important implications for clinical outcomes and targeted therapy development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Science and Therapeutics Division, Fred Hutch Cancer Center, Seattle, United States.
- Ben Towne Center for Childhood Cancer and Blood Disorders Research, Seattle Children's Research Institute, Seattle, United States.
- Pacific Biosciences, Menlo Park, United States.
- St. Jude Children's Research Hospital, Memphis, United States.
- Department of Pediatrics, University of Washington, Seattle, United States.
ORCID-Profile: Olivia G Waltner, April A Apfelbaum, Emma D Wrenn, Mark A Mendoza, Anand G Patel, Elizabeth R Lawlor, Scott N Furlan
Förderung
- NCI NIH HHS
- NIH HHS
- AACR-QuadW Foundation Sarcoma Research Fellowship
- Fred Hutch/University of Washington/Seattle Children's Cancer Center Consortium NCI Cancer Center Support
- National Cancer Institute
- Sam Day Foundation
- National Institutes of Health
- Fred Hutch/University of Washington/Seattle Children’s Cancer Center Consortium NCI Cancer Center Support
Zitieren
APA
Waltner, O. G., Apfelbaum, A. A., Wrenn, E. D., Bhise, S. S., Kanaan, S. B., Green Gladden, R., Mendoza, M. A., Volden, R., Kronenberg, Z., Patel, A. G., Dyer, M. A., Sarthy, J. F., Lawlor, E. R., & Furlan, S. N. (2026). Multimodal single-cell analyses reveal distinct fusion-regulated transcriptional programs in Ewing sarcoma. eLife, 14. https://doi.org/10.7554/elife.109124
Vancouver
Waltner OG, Apfelbaum AA, Wrenn ED, Bhise SS, Kanaan SB, Green Gladden R, et al. Multimodal single-cell analyses reveal distinct fusion-regulated transcriptional programs in Ewing sarcoma. eLife. 2026;14. doi:10.7554/elife.109124
BibTeX
@article{Waltner2026,
author = {Waltner, Olivia G and Apfelbaum, April A and Wrenn, Emma D and Bhise, Shruti S and Kanaan, Sami B and Green Gladden, Rula and Mendoza, Mark A and Volden, Roger and Kronenberg, Zev and Patel, Anand G and Dyer, Michael A and Sarthy, Jay F and Lawlor, Elizabeth R and Furlan, Scott N},
title = {Multimodal single-cell analyses reveal distinct fusion-regulated transcriptional programs in Ewing sarcoma},
journal = {eLife},
year = {2026},
volume = {14},
doi = {10.7554/elife.109124}
}
EUVIMED